Literature DB >> 1946880

Effects of potentially phobic conditioned stimuli on retention, reconditioning, and extinction of the conditioned skin conductance response.

A M Schell1, M E Dawson, K Marinkovic.   

Abstract

Discriminative classical conditioning of skin conductance responses (SCRs) was studied in 163 college students as a function of four variables: CS type (potentially phobic versus neutral conditioned stimuli), Sex of the subject, Interstimulus interval (ISI) during conditioning (.5 versus 8 s), and Retention interval between conditioning and retention assessment (1 versus 6 months). CS type did not affect acquisition, retention, or reconditioning of the differential conditioned responses. The effect of CS type was highly significant during extinction, with differential SCRs to CS+ and CS- being greater with potentially phobic conditioned stimuli. This was true for both sexes, both the .5-s and the 8-s ISI, and after a 1-month or a 6-month retention interval. Moreover, SCRs conditioned to phobic conditioned stimuli with the .5-s ISI persisted even after subjects' cognitive expectancy of the UCS, which was measured on a trial-by-trial basis, had completely extinguished. The results indicate that the effect of potentially phobic conditioned stimuli on the conditioned skin conductance response is unique to resistance to extinction-they affect not learning but unlearning of the autonomic response.

Entities:  

Mesh:

Year:  1991        PMID: 1946880     DOI: 10.1111/j.1469-8986.1991.tb00403.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  16 in total

1.  The derived generalization of thought suppression.

Authors:  Nic Hooper; Jo Saunders; Louise McHugh
Journal:  Learn Behav       Date:  2010-05       Impact factor: 1.986

2.  Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

Authors:  Catherine M Brignell; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

3.  The transfer of respondent eliciting and extinction functions through stimulus equivalence classes.

Authors:  M J Dougher; E Augustson; M R Markham; D E Greenway; E Wulfert
Journal:  J Exp Anal Behav       Date:  1994-11       Impact factor: 2.468

4.  A derived transfer of simple discrimination and self-reported arousal functions in spider fearful and non-spider-fearful participants.

Authors:  Sinéad Smyth; Dermot Barnes-Holmes; John P Forsyth
Journal:  J Exp Anal Behav       Date:  2006-03       Impact factor: 2.468

5.  The doxastic shear pin: delusions as errors of learning and memory.

Authors:  S K Fineberg; P R Corlett
Journal:  Cogn Neuropsychiatry       Date:  2016-02-15       Impact factor: 1.871

6.  Fear conditioning in adolescents with anxiety disorders: results from a novel experimental paradigm.

Authors:  Jennifer Y F Lau; Shmuel Lissek; Eric E Nelson; Yoon Lee; Roxann Roberson-Nay; Kaitlin Poeth; Jessica Jenness; Monique Ernst; Christian Grillon; Daniel S Pine
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-01       Impact factor: 8.829

Review 7.  Enhancing exposure-based therapy from a translational research perspective.

Authors:  Stefan G Hofmann
Journal:  Behav Res Ther       Date:  2007-06-17

Review 8.  Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.

Authors:  Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2007-05-03

9.  An alternative scoring method for skin conductance responding in a differential fear conditioning paradigm with a long-duration conditioned stimulus.

Authors:  Suzanne L Pineles; Matthew R Orr; Scott P Orr
Journal:  Psychophysiology       Date:  2009-06-22       Impact factor: 4.016

Review 10.  D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms.

Authors:  Christian Grillon
Journal:  Biol Psychiatry       Date:  2009-06-11       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.